Viral Infection: What is a Cure?; polyDNA Adds New Webpage to Buy-Gene-Eden.com
Many people have a misconception about what a “cure” of a viral infection means. Recently, polyDNA added a new webpage to its website designed to answer this question.
Rochester, NY (PRWEB) July 18, 2013
In recent months, polyDNA has received many E-mails and letters asking if Gene-Eden-VIR, a natural antiviral oral supplement, can cure their infection. To answer this, and related questions, polyDNA updated its website.
The following is an excerpt from a new webpage entitled “Viral Infection: What is a Cure?”
“To start with, it is beneficial to understand that infection with a virus, is ‘caused by the presence of a virus in the body. … The vast majority of human viral infections can be effectively fought by the body's own immune system…’(Medterms.com) (1)
‘Skin, the largest body organ, provides both a physical and a chemical barrier against the outside world. The skin forms a protective layer that completely wraps around the body, shielding blood vessels, nerves, muscles, organs, and bones.’ (humanillness.com) (2) Skin is normally the body's first line of defense against viruses.
However, many viruses have learned how to penetrate this first line of defense. In fact, the CDC says that these viruses are transmitted through ‘… skin that looks normal.’ (3)
Think of two armies, one is trying to protect a piece of land, and the other is trying to invade and conquer. The protecting army is the immune system, and the invading army is the virus. If the immune system army is capable of preventing the virus army from establishing a post, or a ‘beach head,’ on the immune system's territory, then the immune system has won.
Another case is where the invading viral army is able to conquer a small piece of the land and bring it under its control. Let us call this piece of land the home base. Scientists call this case viral latency. Most of the land is free of foreign soldiers, but from time to time, some foreign soldiers sneak out of the home base and attack local targets. The observed damages that these foreign soldiers inflict on local targets, or the observed fights in these local targets between the two armies, is what the medical profession call symptoms. A symptom is no more than a local scrimmage between the local and foreign forces.
A collection of one or more symptoms is called a disease.
The Merriam-Webster dictionary defines a cure as a treatment method that brings about a ‘recovery from a disease’ or ‘remission of signs or symptoms of a disease especially during a prolonged period of observation.’ (Merriam-Webster.com) (4)
Using our two armies example, when the immune system army is able to destroy the foreign forces attacking local targets, the symptoms disappear. Such an event is called a recovery or remission.
However, a treatment method that does not destroy the home base is not a cure! After all, the foreign forces can continue to sneak out of the home base and attack local targets, that is, cause new symptoms, outbreaks, flare-ups, outburst, etc. Note that even the Webster dictionary fails to distinguish between cure and remission.”
polyDNA encourages those with questions concerning viral infections and cures to learn more by visiting the new webpage that addresses these issues at: http://www.buy-gene-eden.com/What-is-a-cure.php
To learn more about Gene-Eden-VIR and herpes, visit http://www.gene-eden-kill-virus.com/Herpes-Remedy.php.
polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.
In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.
polyDNA developed Gene-Eden-VIR , an antiviral natural remedy that helps the immune system kill latent viruses.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/7/prweb10940959.htm